InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,667.20
(
0.64%
)
US TECH 100
19,816.80
(
-0.15%
)
Dow Jones
40,954.48
(
1.85%
)
Brent Oil
83.32
(
-1.22%
)
Bitcoin
65,084.58
(
0.36%
)
Post# of 252611
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11534
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: DewDiligence post# 193854

Tuesday, 07/28/2015 10:07:05 PM

Tuesday, July 28, 2015 10:07:05 PM

Post# of 252611
I would have thought that VPAk should at a minimum be a competitor to Gilead. No matter how you want to slice it the fact remains that Gilead continues to exceed expectations while VPAK lags behind.

One would have thought that VPAK should at least equaled the results of Solvaldi yet it is selling at 1/3rd the rate. VPAK is capturing 7.2% of the total Gilead / Abbvie market.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up